Milestone represents a significant step forward in the development of deramiocel for the treatment of Duchenne muscular ...
Ocugen, Inc. (OCGN) announced the European Medicines Agency has granted orphan medicinal product designation for OCU410ST for the ...
TORONTO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Prime Dividend Corp. (The "Company") declares its monthly distribution of $0.06617 ...